What, if Any, Role Is There for BRAF-Targeted Therapy in BRAF-Mutant Melanoma?
Year: 2022
Type: editorial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.22.01066
Author: Ryan J. Sullivan
Institution: Massachusetts General Hospital
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W4286491167